China Pharma Holdings (CPHI) Share-based Compensation Growth (1y) (2011 - 2025)
China Pharma Holdings (CPHI) Share-based Compensation Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 26.47% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 47.06% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 8.79% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 281.05% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 92.83% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 5.49% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 61.54% |
| 10 | China Pharma Holdings | 629,344.02 | 460,870.02 | 285,487.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 563.95% |
| Dec 31, 2024 | 668.29% |
| Mar 31, 2024 | 110.00% |
| Dec 31, 2023 | -140.70% |
| Sep 30, 2023 | 850.54% |
| Jun 30, 2023 | -345.54% |
| Mar 31, 2023 | 116.67% |
| Dec 31, 2022 | 194,014.07% |
| Sep 30, 2022 | 1,212.08% |
| Mar 31, 2014 | -43.47% |
| Jun 30, 2013 | -365.73% |
| Mar 31, 2013 | 300.95% |
| Jun 30, 2012 | 112.72% |
| Mar 31, 2012 | 34.83% |
| Dec 31, 2011 | -10.53% |
| Sep 30, 2011 | -5.58% |